Ischemia as a common trigger for Alzheimer's disease

Area of Science:

• Neurology
• Gerontology
• Pathology

Background:

• Alzheimer's disease (AD) pathogenesis involves beta-amyloid accumulation and cognitive decline.
• Vascular pathology, common in individuals over 65, is a frequent cause of AD, linked to cerebrovascular disease.
• Vascular insults like atherosclerosis and ischemia trigger inflammation, neuronal death, and amyloid buildup.

Purpose of the Study:

• To summarize the mechanisms by which brain ischemia contributes to Alzheimer's disease development.
• To review interventions targeting brain ischemia reversal.
• To discuss the clinical relevance of these interventions for AD.

Main Methods:

• Review of preclinical studies on hyperbaric oxygen therapy (HBOT).
• Analysis of the pathological mechanisms linking brain ischemia to AD.
• Synthesis of current research on ischemia-reversing interventions.

Main Results:

• HBOT demonstrated preclinical efficacy in reversing brain ischemia.
• HBOT alleviated inflammation, reduced beta-amyloid, promoted white matter regeneration, and enhanced brain performance.
• Ischemia-induced pathways are critical in AD development.

Conclusions:

• Brain ischemia is a significant factor in Alzheimer's disease etiology.
• Interventions like HBOT that reverse ischemia hold therapeutic potential for AD.
• Further clinical research is warranted to validate these findings for patient care.